Acurian Contributes 56% of Total Randomizations and Saves Three Months of Enrollment Time for a Critical Phase II Study in Stress Urinary Incontinence

Urology

Stress Incontinence

For the biopharmaceutical company, rapid completion of its study was critical to its commercial success.

Read More »